General form of registration statement for all companies including face-amount certificate companies

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.21.1
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Class A/B Shares
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2017 16,631 0 0      
Beginning balance at Dec. 31, 2017       $ 7,772 $ (12,982) $ (5,211)
Net loss         (8,711) (8,711) [1]
Shares issued to acquiree in connection with reverse takeover [1]           0
Issuance of supervoting shares [1]           0
Shares issued in connection with conversion of convertible debentures, shares 1,947          
Shares issued in connection with conversion of convertible debentures       3,961 3,961
Issuance of shares associated with acquisitions, shares 88          
Issuance of shares associated with acquisitions       370 370
Issuance of Series B preferred stock, net of issuance costs, shares 9,831          
Issuance of Series B preferred stock, net of issuance costs       41,873 41,873
Issuance of warrants in exchange for services       87   87
Share-based compensation expense       270   270
Ending balance, shares at Dec. 31, 2018 28,497          
Ending balance at Dec. 31, 2018   $ 0 $ 0 54,333 (21,693) 32,640
Net loss         (49,934) (49,934) [1]
Adoption of lease accounting standard         (847) (847)
Issuance of subordinate voting shares in exchange for Class A/B shares, net (28,497) 28,497        
Private placement in connection with reverse takeover, net, shares   3,433        
Private placement in connection with reverse takeover, net       36,762 36,762
Shares issued to acquiree in connection with reverse takeover, shares   130        
Shares issued to acquiree in connection with reverse takeover       1,513 1,513 [1]
Issuance of supervoting shares, shares     203      
Issuance of supervoting shares       40 40 [1]
Exercise of options, shares   125        
Exercise of options       127 127
Issuance of warrants in exchange for services           0
Share-based compensation expense, shares   659        
Share-based compensation expense       3,385 3,385
Ending balance, shares at Dec. 31, 2019 0 32,844 203      
Ending balance at Dec. 31, 2019       96,160 (72,474) 23,686 [1]
Net loss   (7,874) (7,874)
Shares issued to acquiree in connection with reverse takeover           0
Issuance of supervoting shares           0
Issuance of warrants in exchange for services           0
Share-based compensation expense, shares   144        
Share-based compensation expense       1,612   1,612
Ending balance, shares at Mar. 31, 2020 0 32,988 203      
Ending balance at Mar. 31, 2020       97,772 (80,348) 17,424
Beginning balance, shares at Dec. 31, 2019 0 32,844 203      
Beginning balance at Dec. 31, 2019       96,160 (72,474) 23,686 [1]
Net loss         (21,910) (21,910) [1]
Shares issued to acquiree in connection with reverse takeover [1]           0
Issuance of supervoting shares [1]           (39)
Shares issued in connection with convertible debenture offering, shares   250        
Shares issued in connection with convertible debenture offering       62 62
Shares issued in connection with subordinate voting share offering, shares   23,000        
Shares issued in connection with subordinate voting share offering       25,021 25,021
Shares issued in connection with conversion of convertible debentures, shares   375      
Shares issued in connection with conversion of convertible debentures       75 75
Issuance of shares associated with acquisitions, shares   150      
Issuance of shares associated with acquisitions       179   $ 179
Exercise of options, shares           0
Exercise of warrants, shares   750      
Exercise of warrants       210 $ 210
Issuance of warrants in exchange for services       1,556 1,556
Issuance of stock options associated with acquisitions       116 116
Reduction in supervoting share purchase price       (39) (39)
Share-based compensation expense, shares   248      
Share-based compensation expense       2,200 2,200
Ending balance, shares at Dec. 31, 2020 0 57,617 203      
Ending balance at Dec. 31, 2020       125,540 (94,384) 31,156 [1]
Net loss   (6,719) (6,719)
Shares issued to acquiree in connection with reverse takeover           0
Issuance of supervoting shares           0
Shares issued in connection with conversion of convertible debentures, shares   1,390      
Shares issued in connection with conversion of convertible debentures       277   277
Issuance of shares associated with acquisitions, shares   22,644      
Issuance of shares associated with acquisitions       34,237   $ 34,237
Exercise of options, shares           0
Exercise of warrants, shares   1,325      
Exercise of warrants       665   $ 665
Issuance of warrants in exchange for services           0
Share-based compensation expense, shares   246      
Share-based compensation expense       287   287
Ending balance, shares at Mar. 31, 2021 0 83,221 203      
Ending balance at Mar. 31, 2021       $ 161,006 $ (101,103) $ 59,903
[1] Restated